You are here

  • Home
  • Archive
  • Volume 2, Issue 1
  • Adalimumab discontinuation in patients with early rheumatoid arthritis who were initially treated with methotrexate alone or in combination with adalimumab: 1 year outcomes of the HOPEFUL-2 study

Citation Tools

Article menu

Download PDFPDF

Rheumatoid arthritis
Original article
Adalimumab discontinuation in patients with early rheumatoid arthritis who were initially treated with methotrexate alone or in combination with adalimumab: 1 year outcomes of the HOPEFUL-2 study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Tanaka Y, Yamanaka H, Ishiguro N, et al
Adalimumab discontinuation in patients with early rheumatoid arthritis who were initially treated with methotrexate alone or in combination with adalimumab: 1 year outcomes of the HOPEFUL-2 study
RMD Open 2016;2:e000189. doi: 10.1136/rmdopen-2015-000189